fig3

Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy

Figure 3. (A) The procedure to produce hybrid nanoparticles by membrane fusion. Liposomes with targeting molecules on the surface can be delivered into EVs through membrane fusion[79]. Copyright 2018 WILEY-VCH. (B) The procedure to produce hybrid nanoparticles by membrane coating[80]. Copyright 2020 Ivyspring International Publisher. (C) The fusion of the targeting peptide with LAMP-2B[66]. Copyright 2021 Ivyspring International Publisher. (D) The fusion of the delivery molecule with CD63[81]. Copyright 2018 Springer Nature. (E) Targeted modification of EVs based on chemical covalent reactions[82]. Copyright 2021 Elsevier. (F) Targeted modification of EVs based on chemical non-covalent reactions[82]. Copyright 2021 Elsevier. LAMP-2B: Lysosome-associated membrane glycoprotein 2B.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/